Cempra Inc. (CEMP) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Cempra Inc. (CEMP) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on CEMP
Cempra's 7.25 Million shares sold at 14% discount 10:13 a.m. June 14, 2013 - MarketWatch.com
Modest gains for Cempra's IPO in trading debut 1:27 p.m. Feb. 3, 2012 - MarketWatch.com

Other News on CEMP
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape 9:25 a.m. Nov. 13, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 9:10 a.m. Nov. 6, 2014 - Zacks.com
Why Cempra (CEMP) Could Be Positioned for a Surge? - Tale of the Tape 8:31 a.m. Nov. 6, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 6:16 a.m. Nov. 4, 2014 - Zacks.com
Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape 9:25 a.m. Oct. 31, 2014 - Zacks.com
Cempra's (CEMP) CEO Prabha Fernandes on Q3 2014 Results - Earnings Call Transcript 11:16 p.m. Oct. 29, 2014 - Seeking Alpha
10-Q: CEMPRA, INC. 4:08 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Wednesday’s close 5:35 p.m. Oct. 28, 2014 - Seeking Alpha
La Jolla Pharmaceutical Co. (LJPC) Jumps: Stock Rises 10.3% - Tale of the Tape 9:32 a.m. Oct. 27, 2014 - Zacks.com
Strength Seen in Regulus (RGLS): Stock Soars 103.1% - Tale of the Tape 9:25 a.m. Oct. 23, 2014 - Zacks.com
Corium International (CORI) Jumps: Stock Adds 8.9% - Tale of the Tape 9:52 a.m. Oct. 22, 2014 - Zacks.com
Enanta (ENTA) Worth Watching: Stock Moves 6.9% Higher - Tale of the Tape 9:41 a.m. Oct. 21, 2014 - Zacks.com
ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape 8:44 a.m. Oct. 21, 2014 - Zacks.com
Tetraphase (TTPH) in Focus: Stock Gains 19.9% - Tale of the Tape 9:46 a.m. Oct. 20, 2014 - Zacks.com
ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape 9:32 a.m. Oct. 17, 2014 - Zacks.com
Aquinox Pharmaceuticals (AQXP) Jumps: Stock Soars 22.4% - Tale of the Tape 9:27 a.m. Oct. 17, 2014 - Zacks.com
Tetraphase (TTPH) Crumbles: Stock Tanks by 15% - Tale of the Tape 8:55 a.m. Oct. 17, 2014 - Zacks.com
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7% - Tale of the Tape 9:25 a.m. Oct. 16, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4% - Tale of the Tape 9:32 a.m. Oct. 15, 2014 - Zacks.com

Press Releases on CEMP
Cempra to Receive BARDA Funding for 1b and Start-Up of Phase 2/3 Solithromycin Pediatric Studies 6:01 a.m. Nov. 19, 2014 - GlobeNewswire
Cempra to Present at Two Upcoming Investor Conferences 4:07 p.m. Nov. 10, 2014 - GlobeNewswire
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update 3:07 p.m. Oct. 29, 2014 - GlobeNewswire
Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial 3:05 p.m. Sept. 25, 2014 - GlobeNewswire
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan 7:01 a.m. Sept. 9, 2014 - GlobeNewswire
Cempra, Inc. to Present at Three Investor Conferences 3:06 p.m. Aug. 27, 2014 - GlobeNewswire
Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection 7:01 a.m. Aug. 12, 2014 - GlobeNewswire
Cempra, Inc. Reports Second Quarter 2014 Financial and Operating Results 3:06 p.m. July 29, 2014 - GlobeNewswire
Cempra, Inc. to Report Second Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on July 29, 2014 3:06 p.m. July 22, 2014 - GlobeNewswire
Cempra, Inc. to Present at JMP Securities Healthcare Conference 3:05 p.m. June 17, 2014 - GlobeNewswire
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE
Cempra, Inc. to Present at Three Investor Conferences 3:01 p.m. May 8, 2014 - GlobeNewswire
Cempra, Inc. Reports First Quarter 2014 Financial and Operating Results 3:02 p.m. April 29, 2014 - GlobeNewswire
Cempra, Inc. to Report First Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on April 29, 2014 3:06 p.m. April 22, 2014 - GlobeNewswire
Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides 10:01 a.m. April 8, 2014 - ACCESSWIRE
Cempra's Solithromycin Demonstrates Therapeutic Potential Beyond Anti-Bacterial Activity 3:06 p.m. April 3, 2014 - GlobeNewswire
Cempra to Present Late-Breaker on Solithromycin Reducing Inflammation in an Animal Model for Cancer Chemotherapy-Induced Lung Injury 7:14 a.m. March 27, 2014 - GlobeNewswire
Cempra, Inc. to Present at The 21st Annual Future Leaders in the Biotech Industry Conference and Needham & Co. 12th Annual Healthcare Conference 3:12 p.m. March 20, 2014 - GlobeNewswire
Cempra, Inc. to Present at Barclays Capital 2014 Global Healthcare Conference and 26th Annual ROTH Conference 3:59 a.m. March 7, 2014 - GlobeNewswire
Cempra, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results 4:15 p.m. Feb. 27, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 3

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Updated Category News Views 3

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
Innventure Faces Chaotic Legal Storm Over DarkNX Scandal

Updated Category News Views 1

Innventure's DarkNX Project: From Boon to Bane The stock market is no stranger to seismic shifts, but Innventure, Inc.'s recent plunge is a testament to the catastrophic impact missteps can unleash. This whole DarkNX debacle feels more like a meticulous car wreck than a business evolution. Unpacking the Allegations Sitting comfortably under the NASDAQ:INV ticker,...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Greenberg Traurig Eyes Accolades in Middle East Awards

Updated Category News Views 3

Greenberg Traurig Aims for Middle Eastern Legal Dominance Ah, the legal world, where firms jostle like bulls in a market for the prestige of an award—it's not just about the courtroom victories, but also about snatching the right titles at glossy ceremonies. On the docket this time: Greenberg Traurig has its sights set on several prime accolades at the Law Middle East...

Continue Reading
California Contractors Honored for Safety Commitment

Updated Category News Views 9

Commitment to Safety in the Construction Industry When it comes to construction, safety isn’t an afterthought—it’s woven into the very fabric of every project. The 39th Annual Construction Safety Excellence Awards by the Associated General Contractors of California (AGC of California) pits a spotlight on those embodying this ethos. Industry Leaders in Safety Held on...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 0

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading

Top 5 Most Recently Viewed Articles

RPA Market Set to Surge with Digital Transformation Support

Updated Category News Views 218

Understanding the Growth of the Robotic Process Automation Market The Robotic Process Automation (RPA) market is experiencing remarkable growth, with forecasts indicating an increase from USD 2.8 billion in 2023 to a staggering USD 38.4 billion by 2032. This impressive growth, at a compound annual growth rate (CAGR) of 33.8% from 2024 to 2032, reflects the growing...

Continue Reading
Unlocking Hidden Gems: Two Undervalued China Stocks to Buy

Updated Category News Views 246

Discovering Hidden Opportunities in China's Stock Market As the Chinese stock market experiences a renewed rally, discerning investors are on the lookout for undervalued companies with promising growth prospects. In a landscape dominated by major players like Alibaba and Tencent, two lesser-known stocks are gaining attention: Futu Holdings (NASDAQ: FUTU) and Atour...

Continue Reading
Exploring the Rise of Medical Spas: A Booming Industry

Updated Category News Views 186

Introduction to the Medical Spa Industry The medical spa industry is experiencing an exciting evolution, reflecting a shift in consumer preferences towards services that combine traditional spa ambiance with the expertise of medical professionals. With an increasing focus on aesthetic wellness and anti-aging solutions, we are witnessing an impressive market growth...

Continue Reading
Coherent Corp. Launches Chameleon Discovery LX Laser for Researchers

Updated Category News Views 189

Coherent Corp. Launches an Innovative Femtosecond Laser Coherent Corp. (NYSE: COHR), a renowned leader in the laser and photonics industry, has unveiled the Chameleon Discovery LX, an exciting new addition to its esteemed Chameleon Discovery product line. This revolutionary femtosecond laser is specifically designed for researchers engaged in nonlinear microscopy and...

Continue Reading
Neuronetics Shows Strong Revenue Growth Amid CEO Transition

Updated Category News Views 134

Neuronetics Reports Impressive Q3 2025 Results Neuronetics, Inc., a leader in neurohealth therapies, has shared substantial financial achievements for the third quarter of 2025. The company reported total revenues of $37.3 million, marking an significant adjusted pro forma growth of 11% compared to the same quarter in the previous year. This success can largely be...

Continue Reading